GW PHARMACEUTICALS PLC Comprehensive Income
GW PHARMACEUTICALS PLC reported Comprehensive Income of -$17.15 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-05-03
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$17.15M.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-12-31 was -$11.27M.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-09-30 was $774.00K.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-06-30 was -$10.16M, a 113.57% decline year-over-year.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$43.06M, a 4216.25% decline from fiscal 2019.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was $1.05M.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$295.84M.
- GW PHARMACEUTICALS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$160.45M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$17.15M 10-Q · filed 2021-05-03 | -$28.42M derived: sum of 2 quarters · filed 2021-05-03 | -$27.65M derived: sum of 3 quarters · filed 2021-05-03 | -$37.81M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | -$11.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$10.50M derived: sum of 2 quarters · filed 2021-02-26 | -$20.66M derived: sum of 3 quarters · filed 2021-02-26 | -$43.06M 10-K · filed 2021-02-26 |
| 2020-09-30 | $774.00K 10-Q · filed 2020-11-05 | -$9.39M derived: sum of 2 quarters · filed 2020-11-05 | -$31.78M 10-Q · filed 2020-11-05 | -$37.80M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$10.16M 10-Q · filed 2020-08-07 | -$32.56M 10-Q · filed 2020-08-07 | -$38.57M derived: sum of 3 quarters · filed 2021-05-03 | -$60.11M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$22.39M 10-Q · filed 2021-05-03 | -$28.41M derived: sum of 2 quarters · filed 2021-05-03 | -$49.95M derived: sum of 3 quarters · filed 2021-05-03 | $24.92M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$27.56M derived: sum of 2 quarters · filed 2021-02-26 | $47.31M derived: sum of 3 quarters · filed 2021-02-26 | $1.05M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$21.54M 10-Q · filed 2020-11-05 | $53.33M derived: sum of 2 quarters · filed 2020-11-05 | $7.06M 10-Q · filed 2020-11-05 | -$68.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $74.87M 10-Q · filed 2020-08-07 | $28.60M 10-Q · filed 2020-08-07 | -$46.80M derived: sum of 3 quarters · filed 2021-02-26 | -$126.11M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$46.27M 10-Q · filed 2020-05-11 | -$121.67M derived: sum of 2 quarters · filed 2021-02-26 | -$200.98M derived: sum of 3 quarters · filed 2021-02-26 | -$290.91M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$75.40M 10-K · filed 2021-02-26 | -$154.72M derived: sum of 2 quarters · filed 2021-02-26 | -$244.64M derived: sum of 3 quarters · filed 2021-02-26 | -$309.99M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | -$79.32M 10-Q · filed 2019-11-06 | -$169.24M derived: sum of 2 quarters · filed 2019-11-06 | -$234.59M 10-Q · filed 2019-11-06 | -$295.84M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$89.92M 10-Q · filed 2019-08-07 | -$155.28M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$65.35M 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | -$160.45M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | -$148.65M 10-KT · filed 2019-02-28 |